TABLE OF CONTENTS
1. EXECUTIVE SUMMARY
2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the Study
2.2.1. Research Objective
2.2.2. Assumptions
2.2.3. Limitations
3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Data Mining
3.3. Secondary Research
3.4. Primary Research
3.4.1. Primary Interviews and Information Gathering Process
3.4.2. Breakdown of Primary Respondents
3.5. Forecasting Modality
3.6. Market Size Estimation
3.6.1. Bottom-Up Approach
3.6.2. Top-Down Approach
3.7. Data Triangulation
3.8. Validation
4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.2.1. Advancement in toxicology techniques
4.2.2. Growing pharma R&D expenditure
4.3. Restraints
4.3.1. The lack of skilled professionals
4.4. Opportunities
5. MARKET FACTOR ANALYSIS
5.1. Value Chain Analysis
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining Power of Suppliers
5.2.2. Bargaining Power of Buyers
5.2.3. Threat of New Entrants
5.2.4. Threat of Substitutes
5.2.5. Intensity of Rivalry
5.3. COVID-19 Impact Analysis
5.3.1. Market Impact Analysis
5.3.2. Regional Impact
5.3.3. Opportunity and Threat Analysis
6. GLOBAL TOXICOLOGY CONSULTING MARKET, BY TYPE
6.1. Overview
6.2. Risk Mitigation Strategy Services
6.3. Forensic Investigation Services
6.4. Regulatory Advisory Services
6.5. Litigation Support Services
7. GLOBAL TOXICOLOGY CONSULTING MARKET, BY APPLICATION
7.1. Overview
7.2. Pharmaceutical
7.3. Biotechnology
7.4. Medical Instruments
7.5. Others
8. GLOBAL TOXICOLOGY CONSULTING MARKET, BY END USER
8.1. Overview
8.2. Pharmaceutical Companies
8.3. Medical Device Manufacturers
8.4. Research Institutions
9. GLOBAL TOXICOLOGY CONSULTING MARKET, BY REGION
9.1. Overview
9.1. North America
9.1.1. US
9.1.2. Canada
9.2. Europe
9.2.1. Germany
9.2.2. France
9.2.3. UK
9.2.4. Italy
9.2.5. Spain
9.2.6. Rest of Europe
9.3. Asia-Pacific
9.3.1. China
9.3.2. India
9.3.3. Japan
9.3.4. South Korea
9.3.5. Australia
9.3.6. Rest of Asia-Pacific
9.4. Rest of the World
9.4.1. Middle East
9.4.2. Africa
9.4.3. Latin America
10. COMPETITIVE LANDSCAPE
10.1. Overview
10.2. Competitive Analysis
10.3. Market Share Analysis
10.4. Major Growth Strategy in the Global Toxicology Consulting Market,
10.5. Competitive Benchmarking
10.6. Leading Players in Terms of Number of Developments in the Global Toxicology Consulting Market,
10.7. Key developments and Growth Strategies
10.7.1. New Product Launch/Service Deployment
10.7.2. Merger & Acquisitions
10.7.3. Joint Ventures
10.8. Major Players Financial Matrix
10.8.1. Sales & Operating Income, 2022
10.8.2. Major Players R&D Expenditure. 2022
11. COMPANY PROFILES
11.1. Evalueserve
11.1.1. Company Overview
11.1.2. Financial Overview
11.1.3. Products Offered
11.1.4. Key Developments
11.1.5. SWOT Analysis
11.1.6. Key Strategies
11.2. Gad Consulting
11.2.1. Company Overview
11.2.2. Financial Overview
11.2.3. Products Offered
11.2.4. Key Developments
11.2.5. SWOT Analysis
11.2.6. Key Strategies
11.3. InterBioTox
11.3.1. Company Overview
11.3.2. Financial Overview
11.3.3. Products Offered
11.3.4. Key Developments
11.3.5. SWOT Analysis
11.3.6. Key Strategies
11.4. Intertek
11.4.1. Company Overview
11.4.2. Financial Overview
11.4.3. Products Offered
11.4.4. Key Developments
11.4.5. SWOT Analysis
11.4.6. Key Strategies
11.5. JS Held
11.5.1. Company Overview
11.5.2. Financial Overview
11.5.3. Products Offered
11.5.4. Key Developments
11.5.5. SWOT Analysis
11.5.6. Key Strategies
11.6. PinPoint Testing, LLC
11.6.1. Company Overview
11.6.2. Financial Overview
11.6.3. Products Offered
11.6.4. Key Developments
11.6.5. SWOT Analysis
11.6.6. Key Strategies
11.7. Sharp HealthCare
11.7.1. Company Overview
11.7.2. Financial Overview
11.7.3. Products Offered
11.7.4. Key Developments
11.7.5. SWOT Analysis
11.7.6. Key Strategies
11.8. SLR Consulting
11.8.1. Company Overview
11.8.2. Financial Overview
11.8.3. Products Offered
11.8.4. Key Developments
11.8.5. SWOT Analysis
11.8.6. Key Strategies
11.9. ToxServices
11.9.1. Company Overview
11.9.2. Financial Overview
11.9.3. Products Offered
11.9.4. Key Developments
11.9.5. SWOT Analysis
11.9.6. Key Strategies
11.10. CTEH
11.10.1. Company Overview
11.10.2. Financial Overview
11.10.3. Products Offered
11.10.4. Key Developments
11.10.5. SWOT Analysis
11.10.6. Key Strategies
12. APPENDIX
12.1. References
12.2. Related Reports
LIST OF TABLES
TABLE 1 GLOBAL TOXICOLOGY CONSULTING MARKET, SYNOPSIS, 2019–2032
TABLE 2 GLOBAL TOXICOLOGY CONSULTING MARKET, ESTIMATES & FORECAST, 2019–2032 (USD MILLION)
TABLE 3 GLOBAL TOXICOLOGY CONSULTING MARKET, BY TYPE, 2019–2032 (USD MILLION)
TABLE 4 GLOBAL TOXICOLOGY CONSULTING MARKET, BY APPLICATION, 2019–2032 (USD MILLION)
TABLE 5 GLOBAL TOXICOLOGY CONSULTING MARKET, BY END USER, 2019–2032 (USD MILLION)
TABLE 6 NORTH AMERICA: TOXICOLOGY CONSULTING MARKET, BY TYPE, 2019–2032 (USD MILLION)
TABLE 7 NORTH AMERICA: TOXICOLOGY CONSULTING MARKET, BY APPLICATION, 2019–2032 (USD MILLION)
TABLE 8 NORTH AMERICA: TOXICOLOGY CONSULTING MARKET, BY END USER, 2019–2032 (USD MILLION)
TABLE 9 US: TOXICOLOGY CONSULTING MARKET, BY TYPE, 2019–2032 (USD MILLION)
TABLE 10 US: TOXICOLOGY CONSULTING MARKET, BY APPLICATION, 2019–2032 (USD MILLION)
TABLE 11 US: TOXICOLOGY CONSULTING MARKET, BY END USER, 2019–2032 (USD MILLION)
TABLE 12 CANADA: TOXICOLOGY CONSULTING MARKET, BY TYPE, 2019–2032 (USD MILLION)
TABLE 13 CANADA: TOXICOLOGY CONSULTING MARKET, BY APPLICATION, 2019–2032 (USD MILLION)
TABLE 14 CANADA: TOXICOLOGY CONSULTING MARKET, BY END USER, 2019–2032 (USD MILLION)
TABLE 1 EUROPE: TOXICOLOGY CONSULTING MARKET, BY TYPE, 2019–2032 (USD MILLION)
TABLE 2 EUROPE: TOXICOLOGY CONSULTING MARKET, BY APPLICATION, 2019–2032 (USD MILLION)
TABLE 3 EUROPE: TOXICOLOGY CONSULTING MARKET, BY END USER, 2019–2032 (USD MILLION)
TABLE 4 GERMANY: TOXICOLOGY CONSULTING MARKET, BY TYPE, 2019–2032 (USD MILLION)
TABLE 5 GERMANY: TOXICOLOGY CONSULTING MARKET, BY APPLICATION, 2019–2032 (USD MILLION)
TABLE 6 GERMANY: TOXICOLOGY CONSULTING MARKET, BY END USER, 2019–2032 (USD MILLION)
TABLE 7 FRANCE: TOXICOLOGY CONSULTING MARKET, BY TYPE, 2019–2032 (USD MILLION)
TABLE 8 FRANCE: TOXICOLOGY CONSULTING MARKET, BY APPLICATION, 2019–2032 (USD MILLION)
TABLE 9 FRANCE: TOXICOLOGY CONSULTING MARKET, BY END USER, 2019–2032 (USD MILLION)
TABLE 10 ITALY: TOXICOLOGY CONSULTING MARKET, BY TYPE, 2019–2032 (USD MILLION)
TABLE 11 ITALY: TOXICOLOGY CONSULTING MARKET, BY APPLICATION, 2019–2032 (USD MILLION)
TABLE 12 ITALY: TOXICOLOGY CONSULTING MARKET, BY END USER, 2019–2032 (USD MILLION)
TABLE 13 SPAIN: TOXICOLOGY CONSULTING MARKET, BY TYPE, 2019–2032 (USD MILLION)
TABLE 14 SPAIN: TOXICOLOGY CONSULTING MARKET, BY APPLICATION, 2019–2032 (USD MILLION)
TABLE 15 SPAIN: TOXICOLOGY CONSULTING MARKET, BY END USER, 2019–2032 (USD MILLION)
TABLE 16 UK: TOXICOLOGY CONSULTING MARKET, BY TYPE, 2019–2032 (USD MILLION)
TABLE 17 UK: TOXICOLOGY CONSULTING MARKET, BY APPLICATION, 2019–2032 (USD MILLION)
TABLE 18 UK: TOXICOLOGY CONSULTING MARKET, BY END UER, 2019–2032 (USD MILLION)
TABLE 19 REST OF EUROPE: TOXICOLOGY CONSULTING MARKET, BY TYPE, 2019–2032 (USD MILLION)
TABLE 20 REST OF EUROPE: TOXICOLOGY CONSULTING MARKET, BY APPLICATION, 2019–2032 (USD MILLION)
TABLE 21 REST OF EUROPE: TOXICOLOGY CONSULTING MARKET, BY END USER, 2019–2032 (USD MILLION)
TABLE 22 ASIA-PACIFIC: TOXICOLOGY CONSULTING MARKET, BY TYPE, 2019–2032 (USD MILLION)
TABLE 23 ASIA-PACIFIC: TOXICOLOGY CONSULTING MARKET, BY APPLICATION, 2019–2032 (USD MILLION)
TABLE 24 ASIA-PACIFIC: TOXICOLOGY CONSULTING MARKET, BY END USER, 2019–2032 (USD MILLION)
TABLE 25 JAPAN: TOXICOLOGY CONSULTING MARKET, BY TYPE, 2019–2032 (USD MILLION)
TABLE 26 JAPAN: TOXICOLOGY CONSULTING MARKET, BY APPLICATION, 2019–2032 (USD MILLION)
TABLE 27 JAPAN: TOXICOLOGY CONSULTING MARKET, BY END USER, 2019–2032 (USD MILLION)
TABLE 28 CHINA: TOXICOLOGY CONSULTING MARKET, BY TYPE, 2019–2032 (USD MILLION)
TABLE 29 CHINA: TOXICOLOGY CONSULTING MARKET, BY APPLICATION, 2019–2032 (USD MILLION)
TABLE 30 CHINA: TOXICOLOGY CONSULTING MARKET, BY END USER, 2019–2032 (USD MILLION)
TABLE 31 INDIA: TOXICOLOGY CONSULTING MARKET, BY TYPE, 2019–2032 (USD MILLION)
TABLE 32 INDIA: TOXICOLOGY CONSULTING MARKET, BY APPLICATION, 2019–2032 (USD MILLION)
TABLE 33 INDIA: TOXICOLOGY CONSULTING MARKET, BY END USER, 2019–2032 (USD MILLION)
TABLE 34 AUSTRALIA: TOXICOLOGY CONSULTING MARKET, BY TYPE, 2019–2032 (USD MILLION)
TABLE 35 AUSTRALIA: TOXICOLOGY CONSULTING MARKET, BY APPLICATION, 2019–2032 (USD MILLION)
TABLE 36 AUSTRALIA: TOXICOLOGY CONSULTING MARKET, BY END USER, 2019–2032 (USD MILLION)
TABLE 37 SOUTH KOREA: TOXICOLOGY CONSULTING MARKET, BY TYPE, 2019–2032 (USD MILLION)
TABLE 38 SOUTH KOREA: TOXICOLOGY CONSULTING MARKET, BY APPLICATION, 2019–2032 (USD MILLION)
TABLE 39 SOUTH KOREA: TOXICOLOGY CONSULTING MARKET, BY END USER, 2019–2032 (USD MILLION)
TABLE 40 REST OF ASIA-PACIFIC: TOXICOLOGY CONSULTING MARKET, BY TYPE, 2019–2032 (USD MILLION)
TABLE 41 REST OF ASIA-PACIFIC: TOXICOLOGY CONSULTING MARKET, BY APPLICATION, 2019–2032 (USD MILLION)
TABLE 42 REST OF ASIA-PACIFIC: TOXICOLOGY CONSULTING MARKET, BY END USER, 2019–2032 (USD MILLION)
TABLE 43 REST OF THE WORLD: TOXICOLOGY CONSULTING MARKET, BY TYPE, 2019–2032 (USD MILLION)
TABLE 44 REST OF THE WORLD: TOXICOLOGY CONSULTING MARKET, BY APPLICATION, 2019–2032 (USD MILLION)
TABLE 45 REST OF THE WORLD: TOXICOLOGY CONSULTING MARKET, BY END USER, 2019–2032 (USD MILLION)
TABLE 46 MIDDLE EAST: TOXICOLOGY CONSULTING MARKET, BY TYPE, 2019–2032 (USD MILLION)
TABLE 47 MIDDLE EAST: TOXICOLOGY CONSULTING MARKET, BY APPLICATION, 2019–2032 (USD MILLION)
TABLE 48 MIDDLE EAST: TOXICOLOGY CONSULTING MARKET, BY END USER, 2019–2032 (USD MILLION)
TABLE 49 AFRICA: TOXICOLOGY CONSULTING MARKET, BY TYPE, 2019–2032 (USD MILLION)
TABLE 50 AFRICA: TOXICOLOGY CONSULTING MARKET, BY APPLICATION, 2019–2032 (USD MILLION)
TABLE 51 AFRICA: TOXICOLOGY CONSULTING MARKET, BY END USER, 2019–2032 (USD MILLION)
TABLE 52 LATIN AMERICA: TOXICOLOGY CONSULTING MARKET, BY TYPE, 2019–2032 (USD MILLION)
TABLE 53 LATIN AMERICA: TOXICOLOGY CONSULTING MARKET, BY APPLICATION, 2019–2032 (USD MILLION)
TABLE 54 LATIN AMERICA: TOXICOLOGY CONSULTING MARKET, BY END USER, 2019–2032 (USD MILLION)
LIST OF FIGURES
FIGURE 1 RESEARCH PROCESS
FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL TOXICOLOGY CONSULTING MARKET
FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL TOXICOLOGY CONSULTING MARKET
FIGURE 4 GLOBAL TOXICOLOGY CONSULTING MARKET, SHARE (%), BY TYPE, 2022
FIGURE 5 GLOBAL TOXICOLOGY CONSULTING MARKET, SHARE (%), BY APPLICATION, 2022
FIGURE 6 GLOBAL TOXICOLOGY CONSULTING MARKET, SHARE (%), BY END USER, 2022
FIGURE 7 GLOBAL TOXICOLOGY CONSULTING MARKET, SHARE (%), BY REGION, 2022
FIGURE 8 NORTH AMERICA: TOXICOLOGY CONSULTING MARKET, SHARE (%), BY REGION, 2022
FIGURE 9 EUROPE: TOXICOLOGY CONSULTING MARKET, SHARE (%), BY REGION, 2022
FIGURE 10 ASIA-PACIFIC: TOXICOLOGY CONSULTING MARKET, SHARE (%), BY REGION, 2022
FIGURE 11 REST OF THE WORLD: TOXICOLOGY CONSULTING MARKET, SHARE (%), BY REGION, 2022
FIGURE 12 GLOBAL TOXICOLOGY CONSULTING MARKET: COMPANY SHARE ANALYSIS, 2022 (%)
FIGURE 13 EVALUESERVE: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 14 EVALUESERVE: SWOT ANALYSIS
FIGURE 15 GAD CONSULTING: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 16 GAD CONSULTING: SWOT ANALYSIS
FIGURE 17 INTERBIOTOX: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 18 INTERBIOTOX: SWOT ANALYSIS
FIGURE 19 INTERTEK: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 20 INTERTEK: SWOT ANALYSIS
FIGURE 21 JS HELD.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 22 JS HELD.: SWOT ANALYSIS
FIGURE 23 PINPOINT TESTING, LLC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 24 PINPOINT TESTING, LLC: SWOT ANALYSIS
FIGURE 25 SHARP HEALTHCARE: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 26 SHARP HEALTHCARE: SWOT ANALYSIS
FIGURE 27 SLR CONSULTING: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 28 SLR CONSULTING: SWOT ANALYSIS
FIGURE 29 TOXSERVICES: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 30 TOXSERVICES: SWOT ANALYSIS
FIGURE 31 CTEH: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 32 CTEH: SWOT ANALYSIS
